Quanticate is pleased to announce that we have been recognised as a 4 category winner of the Life Science Reader CRO Leadership Awards 2015 in Quality, Productivity, Regulatory and Innovation.
The CRO Leadership Awards were presented by Life Science Leader magazine and were based on industry research by Nice Insight. Being selected as a winner of a CRO Leadership Award reflects the fact that executives responsible for making or influencing outsourcing decisions at pharmaceutical and biopharmaceutical companies have identified Quanticate as a leading CRO. This is the third year Quanticate has been recognized by the pharmaceutical industry for its leadership and is this year Quanticate has been recognized as a four category winner.
“We are delighted that Quanticate has been recognized for Quality, Regulatory, Productivity, and Innovation for a second year running and was again featured in the CRO leadership awards. I would like to thank the dedication and determination of our employees for consistently performing above and beyond to enable Quanticate to be recognized by our pharmaceutical and biopharmaceutical customers. Our current position as a leading global data-focused CRO is testament to the expertise and reliability of our teams, by focusing on the provision of data related and consultancy services we provide experience and reassurance as well as high quality deliverables to our customers. This has enabled us to excel in clinical trial research for our customers and create long lasting relationships with two of the top five large pharmaceutical companies. ” explained David Underwood, Chief Executive Officer & President.
Receiving these awards continues to strengthen Quanticate’s position in the market as a leading global data-focused CRO. Coupled with the strategic large-scale global partnerships with top pharmaceutical companies in the area of biostatistics and clinical programming, Quanticate has been consistently demonstrating their ability to successfully grow and deliver an industry leading service.